Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Remco van Doorn

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
Differentiation; Research in Biological Diversity|July 3, 2013
Class III β-tubulin, a novel biomarker in the human melanocyte lineageHeiko Locher, Karien E de Rooij, John C M J de Groot, et al.
The Journal of Investigative Dermatology|April 29, 2015
Prognostic Significance of Promoter Hypermethylation and Diminished Gene Expression of SYNPO2 in MelanomaLinda Gao, Karin van den Hurk, Jérémie Nsengimana, et al.
Journal of the American Academy of Dermatology|December 25, 2019
Molecular testing in metastatic basal cell carcinomaBabette J A Verkouteren, Marlies Wakkee, Michel van Geel, et al.
The American Journal of Surgical Pathology|May 16, 2020
Clinical, Histologic, and Molecular Characteristics of Anaplastic Lymphoma Kinase-positive Primary Cutaneous Anaplastic Large Cell LymphomaRutger C Melchers, Rein Willemze, Merel van de Loo, et al.
Acta Dermato-Venereologica|August 18, 2015
Real-life Data on Patient Characteristics, Cost and Effectiveness of Field-directed Treatment for Actinic Keratoses: An Observational StudyMargit C J van Rijsingen, Inge Seubring, Janneke P C Grutters, et al.
Pigment Cell & Melanoma Research|April 18, 2013
Genome-wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanomaLinda Gao, Marjon A Smit, Joost J van den Oord, et al.
Pigment Cell & Melanoma Research|January 19, 2017
Genomic analysis and clinical management of adolescent cutaneous melanomaRoy Rabbie, Mamunur Rashid, Ana M Arance, et al.
Epigenomics|October 30, 2020
Association of HERV-K and LINE-1 hypomethylation with reduced disease-free survival in melanoma patientsMaurizio Cardelli, Remco van Doorn, Lares Larcher, et al.
Clinical Immunology (Orlando, Fla.)|November 4, 2023
Autoantibody subclass predominance is not driven by aberrant class switching or impaired B cell developmentLaurent M Paardekooper, Yvonne E Fillié-Grijpma, Alita J van der Sluijs-Gelling, et al.
Journal of Clinical Immunology|May 8, 2022
T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell TransplantationJanine E Melsen, Monique M van Ostaijen-Ten Dam, Erik B van den Akker, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
Differentiation; Research in Biological Diversity|July 3, 2013
Class III β-tubulin, a novel biomarker in the human melanocyte lineageHeiko Locher, Karien E de Rooij, John C M J de Groot, et al.
The Journal of Investigative Dermatology|April 29, 2015
Prognostic Significance of Promoter Hypermethylation and Diminished Gene Expression of SYNPO2 in MelanomaLinda Gao, Karin van den Hurk, Jérémie Nsengimana, et al.
Journal of the American Academy of Dermatology|December 25, 2019
Molecular testing in metastatic basal cell carcinomaBabette J A Verkouteren, Marlies Wakkee, Michel van Geel, et al.
The American Journal of Surgical Pathology|May 16, 2020
Clinical, Histologic, and Molecular Characteristics of Anaplastic Lymphoma Kinase-positive Primary Cutaneous Anaplastic Large Cell LymphomaRutger C Melchers, Rein Willemze, Merel van de Loo, et al.
Acta Dermato-Venereologica|August 18, 2015
Real-life Data on Patient Characteristics, Cost and Effectiveness of Field-directed Treatment for Actinic Keratoses: An Observational StudyMargit C J van Rijsingen, Inge Seubring, Janneke P C Grutters, et al.
Pigment Cell & Melanoma Research|April 18, 2013
Genome-wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanomaLinda Gao, Marjon A Smit, Joost J van den Oord, et al.
Pigment Cell & Melanoma Research|January 19, 2017
Genomic analysis and clinical management of adolescent cutaneous melanomaRoy Rabbie, Mamunur Rashid, Ana M Arance, et al.
Epigenomics|October 30, 2020
Association of HERV-K and LINE-1 hypomethylation with reduced disease-free survival in melanoma patientsMaurizio Cardelli, Remco van Doorn, Lares Larcher, et al.
Clinical Immunology (Orlando, Fla.)|November 4, 2023
Autoantibody subclass predominance is not driven by aberrant class switching or impaired B cell developmentLaurent M Paardekooper, Yvonne E Fillié-Grijpma, Alita J van der Sluijs-Gelling, et al.
Journal of Clinical Immunology|May 8, 2022
T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell TransplantationJanine E Melsen, Monique M van Ostaijen-Ten Dam, Erik B van den Akker, et al.
Pageof 12